Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,578.84
(
-0.69%
)
US TECH 100
23,593.40
(
-0.85%
)
Dow Jones
45,837.34
(
-0.84%
)
Brent Oil
105.12
(
-1.37%
)
Bitcoin
69,714.21
(
-2.14%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 143763

Wednesday, 06/13/2012 1:04:28 PM

Wednesday, June 13, 2012 1:04:28 PM

Post# of 257259
REGN—Where do you see any suggestion that Roche would seek to sell Fovista only in combination with Lucentis? Something like that has never been done with biologics, as far as I know, and it would encounter practical problems apart from the anti-competitive legal issues.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today